AAAAAA

   
Results: 1-25 |
Results: 25
ASSOCIATION BETWEEN PLASMA HDL-CHOLESTEROL CONCENTRATION AND TAQ1B CETP GENE POLYMORPHISM IN NON-INSULIN-DEPENDENT DIABETES-MELLITUS
Authors: BERNARD S MOULIN P LAGROST L PICARD S ELCHEBLY M PONSIN G CHAPUIS F BERTHEZENE F
Citation: S. Bernard et al., ASSOCIATION BETWEEN PLASMA HDL-CHOLESTEROL CONCENTRATION AND TAQ1B CETP GENE POLYMORPHISM IN NON-INSULIN-DEPENDENT DIABETES-MELLITUS, Journal of lipid research, 39(1), 1998, pp. 59-65
LACK OF ASSOCIATION BETWEEN CAROTID INTIMA-MEDIA THICKNESS AND PARAOXONASE GENE POLYMORPHISM IN NON-INSULIN-DEPENDENT DIABETES-MELLITUS
Authors: CAO HB GIRARDGLOBA A SERUSCLAT A BERNARD S BONDON P PICARD S BERTHEZENE F MOULIN P
Citation: Hb. Cao et al., LACK OF ASSOCIATION BETWEEN CAROTID INTIMA-MEDIA THICKNESS AND PARAOXONASE GENE POLYMORPHISM IN NON-INSULIN-DEPENDENT DIABETES-MELLITUS, Atherosclerosis (Amsterdam), 138(2), 1998, pp. 361-366
EFFICACY OF LOW-DOSE PRAVASTATIN IN PATIENTS WITH MILD HYPERLIPIDEMIAASSOCIATED WITH TYPE-II DIABETES-MELLITUS
Authors: KREMPF M BERTHEZENE F WEMEAU JL MOINADE S DESRIAC I AMELINEAU E PASSA P
Citation: M. Krempf et al., EFFICACY OF LOW-DOSE PRAVASTATIN IN PATIENTS WITH MILD HYPERLIPIDEMIAASSOCIATED WITH TYPE-II DIABETES-MELLITUS, Diabetes & metabolism, 23(2), 1997, pp. 131-136
MEDICAL RECOMMENDATIONS AND REFERENCES ABOUT HYPOLIPIDEMIC DRUGS - ANDEM ALE-POUR-LE-DEVELOPPEMENT-DE-LEVALUATION-MEDICALE)
Authors: SICARD D NOIRY JP ABADIE E APFELBAUM M ARIE E BECRET F DUCIMETIERE P MOLLARD JM POCHET P ROUFFY J THOMAS D VINCENS M BERLIN I BERTHEZENE F BLANCHET F BONNECARRERE M BRUCKERT E CLERC M DAB W DANINOS JM DELAHAYE F DELEBARRE P DROUIN P DUMONT E FERRIERES J FRUCHART JC GASPARD P GERSON M GILSKI J GROS M GILLEMOT C IMBERT JC JACOTOT B JOURDE M LIBERATI A LINCKDUBOST M MENARD J MICHEL JM OLOMBEL MC POLONOVSKI J SALTIEL H VALCKE JC VITALDURAND D
Citation: D. Sicard et al., MEDICAL RECOMMENDATIONS AND REFERENCES ABOUT HYPOLIPIDEMIC DRUGS - ANDEM ALE-POUR-LE-DEVELOPPEMENT-DE-LEVALUATION-MEDICALE), Journal des maladies vasculaires, 22(4), 1997, pp. 249-264
CHARACTERIZATION OF A NEW CASE OF AUTOIMMUNE TYPE-I HYPERLIPIDEMIA - LONG-TERM REMISSION UNDER IMMUNOSUPPRESSIVE THERAPY
Authors: PRUNETA V MOULIN P LABROUSSE F BONDON PJ PONSIN G BERTHEZENE F
Citation: V. Pruneta et al., CHARACTERIZATION OF A NEW CASE OF AUTOIMMUNE TYPE-I HYPERLIPIDEMIA - LONG-TERM REMISSION UNDER IMMUNOSUPPRESSIVE THERAPY, The Journal of clinical endocrinology and metabolism, 82(3), 1997, pp. 791-796
MINIMALLY OXIDIZED LDL AS ESTIMATED BY A NEW METHOD INCREASE IN PLASMA OF TYPE-2 DIABETIC-PATIENTS WITH ATHEROSCLEROSIS OR NEPHROPATHY
Authors: PICARD S TALUSSOT C SERUSCLAT A AMBROSIO N BERTHEZENE F
Citation: S. Picard et al., MINIMALLY OXIDIZED LDL AS ESTIMATED BY A NEW METHOD INCREASE IN PLASMA OF TYPE-2 DIABETIC-PATIENTS WITH ATHEROSCLEROSIS OR NEPHROPATHY, Diabetes & metabolism, 22(1), 1996, pp. 25-30
HYPOLIPEMIC DRUGS
Authors: SICARD D NOIRY JP ABADIE E APFELBAUM M ARIE E BECRET F DUCIMETIERE P MOLLARD JM POCHET P ROUFFY J THOMAS D VINCENS M BERLIN I BERTHEZENE F BLANCHET F BONNECARRERE M BRUCKERT E CLERC M DAB W DANINOS JM DELAHAYE F DELEBARRE P DROUIN P DUMONT E FERRIERES J FRUCHART JC GASPARD P GERSON M GILSKI J GROS M IMBERT JC JACOTOT B JOURDE M LIBERATI A LINCKDUBOST M MENARD JM MICHEL JM OLOMBEL MC POLONOVSKI J SALTIEL H VALCKE JC DURAND DV
Citation: D. Sicard et al., HYPOLIPEMIC DRUGS, Therapie, 51(6), 1996, pp. 623-626
NON-INSULIN-DEPENDENT DIABETES AND REVERSE CHOLESTEROL TRANSPORT
Authors: BERTHEZENE F
Citation: F. Berthezene, NON-INSULIN-DEPENDENT DIABETES AND REVERSE CHOLESTEROL TRANSPORT, Atherosclerosis, 124, 1996, pp. 39-42
ROUND-TABLE DISCUSSION - PRACTICAL ISSUES IN THE MANAGEMENT OF DYSLIPIDEMIC PATIENTS
Authors: JACOTOT B BETTERIDGE J ASSMANN G CASTELLI W DAVIGNON J TURPIN G BERTHEZENE F",SCHAEFFER,YOMTOV,POMMETTA
Citation: B. Jacotot et al., ROUND-TABLE DISCUSSION - PRACTICAL ISSUES IN THE MANAGEMENT OF DYSLIPIDEMIC PATIENTS, Atherosclerosis, 124, 1996, pp. 89-97
ALTERATIONS IN COMPOSITION AND CONCENTRATION OF LIPOPROTEINS AND ELEVATED CHOLESTERYL ESTER TRANSFER IN NON-INSULIN-DEPENDENT DIABETES-MELLITUS (NIDDM)
Authors: ELCHEBLY M POROKHOV B PULCINI T BERTHEZENE F PONSIN G
Citation: M. Elchebly et al., ALTERATIONS IN COMPOSITION AND CONCENTRATION OF LIPOPROTEINS AND ELEVATED CHOLESTERYL ESTER TRANSFER IN NON-INSULIN-DEPENDENT DIABETES-MELLITUS (NIDDM), Atherosclerosis, 123(1-2), 1996, pp. 93-101
MULTIPLE ABNORMALITIES IN THE TRANSFER OF PHOSPHOLIPIDS FROM VLDL ANDLDL TO HDL IN NON-INSULIN-DEPENDENT DIABETES
Authors: ELCHEBLY M PULCINI T POROKHOV B BERTHEZENE F PONSIN G
Citation: M. Elchebly et al., MULTIPLE ABNORMALITIES IN THE TRANSFER OF PHOSPHOLIPIDS FROM VLDL ANDLDL TO HDL IN NON-INSULIN-DEPENDENT DIABETES, European journal of clinical investigation, 26(3), 1996, pp. 216-223
TROGLITAZONE, AN INSULIN ACTION ENHANCER, IMPROVES METABOLIC CONTROL IN NIDDM PATIENTS (VOL 39, PG 701, 1996)
Authors: KUMAR S BOULTON AJM BECKNIELSEN H BERTHEZENE F MUGGEO M PERSSON B SPINAS GA DONOGHUE S LETTIS S STEWARTLONG P
Citation: S. Kumar et al., TROGLITAZONE, AN INSULIN ACTION ENHANCER, IMPROVES METABOLIC CONTROL IN NIDDM PATIENTS (VOL 39, PG 701, 1996), Diabetologia, 39(10), 1996, pp. 1245-1245
PRAVASTATIN MODULATES CHOLESTERYL ESTER TRANSFER FROM HDL TO APO-B-CONTAINING LIPOPROTEINS AND LIPOPROTEIN SUBSPECIES PROFILE IN FAMILIAL HYPERCHOLESTEROLEMIA
Authors: GUERIN M DOLPHIN PJ TALUSSOT C GARDETTE J BERTHEZENE F CHAPMAN MJ
Citation: M. Guerin et al., PRAVASTATIN MODULATES CHOLESTERYL ESTER TRANSFER FROM HDL TO APO-B-CONTAINING LIPOPROTEINS AND LIPOPROTEIN SUBSPECIES PROFILE IN FAMILIAL HYPERCHOLESTEROLEMIA, Arteriosclerosis, thrombosis, and vascular biology, 15(9), 1995, pp. 1359-1368
CHOLESTEROL ESTER TRANSFER AND HIGH-DENSITY-LIPOPROTEIN CONVERSION INNORMOLIPIDEMIC, HYPERCHOLESTEROLEMIC, AND HYPERTRIGLYCERIDEMIC NON-INSULIN-DEPENDENT DIABETICS
Authors: PULCINI T ELCHEBLY M DUSSERRE E BERTHEZENE F PONSIN G
Citation: T. Pulcini et al., CHOLESTEROL ESTER TRANSFER AND HIGH-DENSITY-LIPOPROTEIN CONVERSION INNORMOLIPIDEMIC, HYPERCHOLESTEROLEMIC, AND HYPERTRIGLYCERIDEMIC NON-INSULIN-DEPENDENT DIABETICS, Biochemical and molecular medicine, 55(1), 1995, pp. 54-60
DYSLIPIDEMIA OF DIABETIC-PATIENTS
Authors: BRUN JM DROUIN P BERTHEZENE F JACOTOT B POMETTA D
Citation: Jm. Brun et al., DYSLIPIDEMIA OF DIABETIC-PATIENTS, Diabete et metabolisme, 21(1), 1995, pp. 59-62
OMEGA-3-FATTY-ACIDS IN SMOOTH-MUSCLE CELL PHOSPHOLIPIDS INCREASE MEMBRANE CHOLESTEROL EFFLUX
Authors: DUSSERRE E PULCINI T BOURDILLON MC CIAVATTI M BERTHEZENE F
Citation: E. Dusserre et al., OMEGA-3-FATTY-ACIDS IN SMOOTH-MUSCLE CELL PHOSPHOLIPIDS INCREASE MEMBRANE CHOLESTEROL EFFLUX, Lipids, 30(1), 1995, pp. 35-41
HIGH-DENSITY LIPOPROTEIN-3 STIMULATES PHOSPHATIDYLCHOLINE BREAKDOWN AND STEROL TRANSLOCATION IN RAT AORTIC SMOOTH-MUSCLE CELLS BY A PHOSPHOLIPASE-C PROTEIN KINASE-C-DEPENDENT PROCESS
Authors: DUSSERRE E PULCINI T BOURDILLON MC BERTHEZENE F
Citation: E. Dusserre et al., HIGH-DENSITY LIPOPROTEIN-3 STIMULATES PHOSPHATIDYLCHOLINE BREAKDOWN AND STEROL TRANSLOCATION IN RAT AORTIC SMOOTH-MUSCLE CELLS BY A PHOSPHOLIPASE-C PROTEIN KINASE-C-DEPENDENT PROCESS, Biochemical medicine and metabolic biology, 52(1), 1994, pp. 45-52
MECHANISM OF THE GEMFIBROZIL-INDUCED DECREASE IN THE TRANSFER OF CHOLESTEROL ESTERS FROM HIGH-DENSITY-LIPOPROTEINS TO VERY-LOW AND LOW-DENSITY LIPOPROTEINS
Authors: PONSIN G GIRARDOT G BERTHEZENE F
Citation: G. Ponsin et al., MECHANISM OF THE GEMFIBROZIL-INDUCED DECREASE IN THE TRANSFER OF CHOLESTEROL ESTERS FROM HIGH-DENSITY-LIPOPROTEINS TO VERY-LOW AND LOW-DENSITY LIPOPROTEINS, Biochemical medicine and metabolic biology, 52(1), 1994, pp. 58-64
DECREASE IN HIGH-DENSITY-LIPOPROTEIN BINDING-SITES IS ASSOCIATED WITHDECREASE IN INTRACELLULAR CHOLESTEROL EFFLUX IN DEDIFFERENTIATED AORTIC SMOOTH-MUSCLE CELLS
Authors: DUSSERRE E BOURDILLON MC PULCINI T BERTHEZENE F
Citation: E. Dusserre et al., DECREASE IN HIGH-DENSITY-LIPOPROTEIN BINDING-SITES IS ASSOCIATED WITHDECREASE IN INTRACELLULAR CHOLESTEROL EFFLUX IN DEDIFFERENTIATED AORTIC SMOOTH-MUSCLE CELLS, Biochimica et biophysica acta, L. Lipids and lipid metabolism, 1212(2), 1994, pp. 235-244
THE CHOLESTEROL COMEBACK
Authors: MOULIN P BERTHEZENE F
Citation: P. Moulin et F. Berthezene, THE CHOLESTEROL COMEBACK, Annales de medecine interne, 145(4), 1994, pp. 247-252
COMPARATIVE-STUDY OF THE EFFICACY AND TOLERABILITY OF SIMVASTATIN ANDPRAVASTATIN IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA
Authors: DOUSTEBLAZY P RIBEIRO VG SEED M BERTHEZENE F DEVULDER B FARNIER M GANCEL A GAUTIER D DEGENNES JL HESPEL JP LATAPIE JL REMY JM ROGER P TATER D THOMAS M AVILA J SILVA PSE GONCALVES FR VANHAFE P SIMOES L HUGHES E RYLANCE P WRAY R WILKINSON P
Citation: P. Dousteblazy et al., COMPARATIVE-STUDY OF THE EFFICACY AND TOLERABILITY OF SIMVASTATIN ANDPRAVASTATIN IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA, Drug investigation, 6(6), 1993, pp. 353-361
HOW TO DEVELOP DRUGS ACTING ON LIPID-META BOLISM
Authors: BERTHEZENE F MUNOZ A BERTHEZENE F MUNOZ A FRUCHART JC PROMEREUR J CHAPMAN J SCHWEIG A EDGAR A MOULIN P CIAVATTI M VAGUE IJ SAUVANET JP LAFONT H LUTTON C PUECH P BOISSEL JP PICOT G SCHEPHER J
Citation: F. Berthezene et al., HOW TO DEVELOP DRUGS ACTING ON LIPID-META BOLISM, Therapie, 48(4), 1993, pp. 307-314
SIMVASTATIN-INDUCED DECREASE IN THE TRANSFER OF CHOLESTEROL ESTERS FROM HIGH-DENSITY-LIPOPROTEINS TO VERY LOW AND LOW-DENSITY LIPOPROTEINS IN NORMOLIPIDEMIC SUBJECTS
Authors: AHNADI CE BERTHEZENE F PONSIN G
Citation: Ce. Ahnadi et al., SIMVASTATIN-INDUCED DECREASE IN THE TRANSFER OF CHOLESTEROL ESTERS FROM HIGH-DENSITY-LIPOPROTEINS TO VERY LOW AND LOW-DENSITY LIPOPROTEINS IN NORMOLIPIDEMIC SUBJECTS, Atherosclerosis, 99(2), 1993, pp. 219-228
DECREASED ABILITY OF HIGH-DENSITY-LIPOPROTEINS TO TRANSFER CHOLESTEROL ESTERS IN NON-INSULIN-DEPENDENT DIABETES-MELLITUS
Authors: AHNADI CE MASMOUDI T BERTHEZENE F PONSIN G
Citation: Ce. Ahnadi et al., DECREASED ABILITY OF HIGH-DENSITY-LIPOPROTEINS TO TRANSFER CHOLESTEROL ESTERS IN NON-INSULIN-DEPENDENT DIABETES-MELLITUS, European journal of clinical investigation, 23(8), 1993, pp. 459-465
HYPERTRIGLYCERIDEMIA - CAUSE OR CONSEQUENCE OF INSULIN RESISTANCE
Authors: BERTHEZENE F
Citation: F. Berthezene, HYPERTRIGLYCERIDEMIA - CAUSE OR CONSEQUENCE OF INSULIN RESISTANCE, Hormone research, 38(1-2), 1992, pp. 39-40
Risultati: 1-25 |